In plain language. Written by scientists. For the global HD community.

Vico Therapeutics have shared interim data about their drug, VO659, which targets the CAG expansion that causes several ...

In an update shared today, uniQure announced alignment with the US drug regulator on key criteria for accelerated approval of ...

Lakshini Mendis is a PhD Candidate at the University of Auckland, in New Zealand. She is currently working in the Centre for Brain Research, under the guidance of Dr Maurice Curtis, and is ...

A new Phase 1 clinical trial for the huntingtin-lowering drug ALN-HTT02 was initiated this week with the first dose given.

Advanced Care Planning is a tool that can allow people living with Huntington’s disease to compassionately engage with loved ...

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community. With your ...

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community. With your ...

At this time of giving, we want to give thanks to you, the Huntington’s disease (HD) community, for all you have done for HD ...

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community. With your ...

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community. With your ...